Portfolio company
Genie
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops non-invasive diagnostics using menstrual blood to study uterine molecular biomarkers for patients experiencing infertility.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Endogene.Bio
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
Afynia
This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.
Endometrics
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
Freya Biosciences
This company develops microbial immunotherapies targeting the vaginal microbiome to treat infertility and other reproductive health conditions for women.
level zero health
This company develops wearable DNA-based sensors that provide continuous hormone monitoring for patients undergoing fertility treatments and clinicians managing reproductive health.
FemTech
This company provides artificial intelligence-powered fertility treatments and clinical care for patients experiencing infertility.
Unravel Health
This company develops a palm-sized device for monitoring multiple hormones from saliva samples at home for women and clinical research partners.
Emm
This company develops a smart menstrual cup with integrated sensors that tracks flow and cycle data for people who menstruate.
